Avalo Therapeutics, Inc. (AVTX) vs MiMedx Group, Inc. (MDXG)
A side-by-side comparison of Avalo Therapeutics, Inc. and MiMedx Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVTX
Avalo Therapeutics, Inc.
$13.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MDXG
MiMedx Group, Inc.
$4.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AVTX vs MDXG
growth of $100 · dividends reinvested · last 10yAVTX -99.9% (-48.7%/yr)MDXG -47.0% (-6.1%/yr)MDXG compounded faster over this window
Log scale — wide-divergence pair
AVTX MDXG
AVTX vs MDXG: by the numbers
- •AVTX is the larger company ($714M vs $673M market cap).
- •MDXG is profitable (1.76% net margin) while AVTX runs a net loss (-170055.93%).
- •MDXG grew revenue faster over the past five years (6.36% vs -60.88% CAGR).
Metrics side by side
Valuation
| Metric | AVTX | MDXG |
|---|---|---|
| P/E ratio | N/A | 115.50 |
| P/S ratio | 12107.91 | 1.90 |
| P/B ratio | 1.59 | 3.12 |
| EV / EBITDA | N/A | 26.41 |
| FCF yield | N/A | 6.03% |
Profitability
| Metric | AVTX | MDXG |
|---|---|---|
| Gross margin | 100.00% | 78.85% |
| Operating margin | -123601.69% | 15.26% |
| Net margin | -170055.93% | 1.76% |
| ROE | -22.36% | 2.89% |
| ROIC | -19.45% | 1.97% |
Growth (annualized)
| Metric | AVTX | MDXG |
|---|---|---|
| Revenue CAGR (5Y) | -60.88% | 6.36% |
| Total return CAGR (5Y) | -70.04% | -4.94% |
Frequently asked
- Which has grown faster, AVTX or MDXG?
- Over the past five years, MDXG grew revenue faster — AVTX at a -60.88% CAGR versus MDXG at 6.36%.
- Is AVTX or MDXG more profitable?
- MDXG runs the higher net margin — AVTX at -170055.93% versus MDXG at 1.76%.
- How have AVTX and MDXG total returns compared?
- Over the past 10 years, AVTX delivered -48.70% and MDXG delivered -6.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MiMedx P/E ratioAvalo Therapeutics ROEMiMedx ROEAvalo Therapeutics operating marginMiMedx operating marginAvalo Therapeutics revenue growthMiMedx revenue growthAvalo Therapeutics free cash flowMiMedx free cash flow
Avalo Therapeutics & MiMedx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.